Prevalence and factors associated with preventable drug-related emergency department visits (DREDp) in elderly patients

被引:2
作者
Phoemlap, Parinya [1 ]
Vadcharavivad, Somratai [1 ]
Musikatavorn, Khrongwong [2 ,3 ,4 ]
Areepium, Nutthada [1 ]
机构
[1] Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Pharm Practice, Bangkok 10330, Thailand
[2] Chulalongkorn Univ, Fac Med, Dept Emergency Med, Bangkok 10330, Thailand
[3] King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Bangkok 10330, Thailand
[4] Chulalongkorn Univ, Fac Med, Dept Med, Bangkok 10330, Thailand
来源
BMC EMERGENCY MEDICINE | 2024年 / 24卷 / 01期
关键词
Elderly; Emergency department visit; Drug-related problems; Adverse drug events; ADVERSE; MEDICATION; EVENTS; RECOGNITION; ADMISSIONS; PEOPLE;
D O I
10.1186/s12873-024-01102-x
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background The prevalence of emergency department (ED) visits among the elderly is high and increasing. While emergency services for the elderly involve many factors, drug-related problems (DRPs) that can worsen patient conditions are less frequently discussed. This study investigates the prevalence of preventable drug-related ED visits (DREDp) and the characteristics of DRPs in elderly ED patients through a comprehensive medication review. Methods A cross-sectional study was conducted at a non-trauma ED of a university-affiliated tertiary-care hospital. All adult patients aged 60 years and older who were on medications and visited the ED were included. A clinical pharmacist conducted comprehensive medication reviews for each patient. Patients were classified as experiencing drug-related ED visits (DRED) if their primary reason for the visit was associated with a DRP, as determined by both the physician and pharmacist. DRPs attributed to medication errors were categorized as preventable, while other DRPs were assessed for preventability using modified Schumock and Thornton criteria. Results The study involved 351 patients with a mean age of 75.5 years (SD 9.3) and an equal male-to-female ratio of ED visits. The median number of comorbidities was five (IQR 3-6), with about half of the patients taking ten or more medications. The interdisciplinary team classified 43 patients (12.3%) as DREDp, accounting for 58.1% of the 74 (21.1%) drug-related ED visits. All medication errors categorized as causing harm (level E and higher) occurred within the DREDp group, constituting approximately half of all DREDp (22 cases, 51.2%). Approximately two-thirds of drug-related ED visits were associated with adverse drug events (ADEs), predominantly involving antithrombotics, oral hypoglycemic agents, and antineoplastics. Multivariable analysis identified that ED visits involving potentially inappropriate medications (PIMs) according to the STOPP criteria and the presence of multiple comorbidities (six or more concurrent diseases) were significantly associated with DREDp. Conclusions About one in ten elderly patients visited the ED due to preventable DRPs. The majority of DRPs leading to ED visits were ADEs. Both the prescription of PIMs and the presence of multiple comorbidities were significantly associated with DREDp.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Drug-related emergency department visits: prevalence and risk factors
    Nymoen, Lisbeth Damlien
    Bjork, Malin
    Flatebo, Trude Eline
    Nilsen, Merethe
    Godo, Aasmund
    Oie, Erik
    Viktil, Kirsten Kilvik
    INTERNAL AND EMERGENCY MEDICINE, 2022, 17 (05) : 1453 - 1462
  • [2] Factors Associated with Drug-Related Emergency Department Visits at a Teaching Hospital in Malaysia
    Ab Rahman A.F.
    Jatau A.I.
    Aung M.M.T.
    Tuan Kamauzaman T.H.
    Pharmaceutical Medicine, 2017, 31 (3) : 175 - 181
  • [3] Drug-related visits to the emergency department in a Spanish university hospital
    Castro, Isabel
    Guardiola, Jose Ma
    Tuneu, Laura
    Luisa Sala, Ma
    Jose Faus, Ma
    Antonia Mangues, Ma
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 727 - 735
  • [4] Prevalence of Drug-Related Emergency Department Visits at a Teaching Hospital in Malaysia
    Jatau A.I.
    Aung M.M.T.
    Kamauzaman T.H.T.
    Rahman A.F.A.
    Drugs - Real World Outcomes, 2015, 2 (4) : 387 - 395
  • [5] Prevalence and Categorization of Drug-Related Problems in the Emergency Department
    Haag, Jordan D.
    Bellamkonda, Venkatesh R.
    Perinpam, Larshan
    Peters, Bradley J.
    Sunga, Kharmene L.
    Gross, Courtney L.
    Dierkhising, Ross A.
    Baudoin, Matthew R.
    Rudis, Maria, I
    JOURNAL OF EMERGENCY MEDICINE, 2022, 63 (02) : 192 - 198
  • [6] Drug-related visits to the emergency department in a Spanish university hospital
    Isabel Castro
    José Mª Guardiola
    Laura Tuneu
    Mª Luisa Sala
    Mª José Faus
    Mª Antonia Mangues
    International Journal of Clinical Pharmacy, 2013, 35 : 727 - 735
  • [7] Development and Validation of a Trigger Tool for Identifying Drug-Related Emergency Department Visits
    Hwang, Sung-Hee
    Ah, Young-Mi
    Jun, Kwang-Hee
    Jung, Jae-Woo
    Kang, Min-Gyu
    Park, Hye-Kyung
    Lee, Eui-Kyung
    Chung, Jee-Eun
    Kim, Sang-Heon
    Lee, Ju-Yeun
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (16)
  • [8] Drug-related emergency department visits in older patients: an applicability and reliability study of an existing assessment tool
    Kempen, Thomas Gerardus Hendrik
    Hedman, Anton
    Gillespie, Ulrika
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (04) : 1078 - 1082
  • [9] Drug-related emergency department visits: external validation of an assessment tool in a general emergency department population
    Nymoen, Lisbeth D.
    Pettersen, Julie L. S.
    Flatebo, Trude. E.
    Oie, Erik
    Viktil, Kirsten K.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2024, 46 (06) : 1327 - 1334
  • [10] Prevalence of adverse drug reactions associated with emergency department visits and risk factors for hospitalization
    Brandariz-Nunez, David
    Ferreiro-Gomez, Manuel
    Suanzes, Jorge
    Margusino-Framinan, Luis
    Camara-Gomez, Maria De la
    Fandino-Orgueira, Jose Manuel
    Martin-Herranz, Maria Isabel
    FARMACIA HOSPITALARIA, 2023, 47 (01) : 20 - 25